Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection.

about

Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection.

Item

http://www.wikidata.org/entity/Q55422383

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Tenofovir decrease hepatocellu ...... atients after liver resection.

@en

Tenofovir decrease hepatocellu ...... atients after liver resection.

@nl

type

Item

label

Tenofovir decrease hepatocellu ...... atients after liver resection.

@en

Tenofovir decrease hepatocellu ...... atients after liver resection.

@nl

altLabel

Tenofovir decrease hepatocellu ...... patients after liver resection

@en

prefLabel

Tenofovir decrease hepatocellu ...... atients after liver resection.

@en

Tenofovir decrease hepatocellu ...... atients after liver resection.

@nl

P1476

Tenofovir decrease hepatocellu ...... patients after liver resection

@en

P2093

Dexin Wang

http://www.w3.org/2001/XMLSchema#string

Haidong Liu

http://www.w3.org/2001/XMLSchema#string

Min Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures

Global cancer statistics, 2012

Hepatocellular carcinoma

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

AASLD guidelines for treatment of chronic hepatitis B.

Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)

The updated incidences and mortalities of major cancers in China, 2011

Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.

P2888

s13027-018-0191-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13027-018-0191-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hui Li

P577

2018-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104481199

http://www.w3.org/2001/XMLSchema#string

P698

29977330

http://www.w3.org/2001/XMLSchema#string

P932

5994044

http://www.w3.org/2001/XMLSchema#string